Treatment of lupus may raise cervical cancer risk

	Tweet

Women with the autoimmune disorder systemic lupus erythematosus (SLE) seem to have a heightened risk for cervical cancer when they’re been treated with the immune-suppressing drug cyclophosphamide, according to a new study.

In fact, women treated with other immunosuppressive drugs should also “be considered potentially at higher risk,” Dr. W. Joseph McCune from University of Michigan Health System, Ann Arbor, told AMN Health.

McCune and his colleagues monitored the occurrence of a precancerous condition called cervical intraepithelial neoplasia, or CIN, over a 3-year period among in 61 women with lupus who were treated with injections of cyclophosphamide and/or azathioprine plus prednisone.

Six women treated with cyclophosphamide alone or in combination with azathioprine developed CIN, the team reports in the Journal of Rheumatology, compared with none of the women treated only with prednisone alone or azathioprine plus prednisone.

Compared with the general population, the rate of CIN was three times higher for women with SLE who were given cyclophosphamide.

Only two additional patients developed abnormal cervical smears in the following 4 years, neither of which showed CIN, the researchers note.

“The frequency of monitoring probably should be increased in high-risk women, but there are no data to support a particular approach,” McCune advised.

Also, his study did not look at whether the type of human papilloma virus (the cause of nearly all cases of cervical cancer) harbored by the women played into their risk for developing CIN. In general, certain virus subtypes are known to be more virulent than others.

The next step to clarify the causal role of cyclophosphamide “would be to serotype HPV in women starting treatment,” McCune added.

SOURCE: Journal of Rheumatology, September 2004.

RELATED STORIES:
Pomegranate extract blocks skin tumors in mice   FDA expands access to experimental melanoma drug   Healthier living could cut 2.8 million cancer cases   Chemo technique can curb some melanomas   Clues on cancer from a zebrafish model of melanoma   Shark cartilage for cancer called ‘pseudoscience’   Dogs sniff out bladder cancer   Blood drive to benefit cancer victim   Viruses are Vaccines’ New Anti-Cancer Weapon   Roche’s Avastin works in third type of cancer   Patients’ age a factor in terminal cancer care   Allergy sufferers ‘less prone to cancer’

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]